Edward Amico

1.0k total citations
9 papers, 775 citations indexed

About

Edward Amico is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Edward Amico has authored 9 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Biological Psychiatry. Recurrent topics in Edward Amico's work include Schizophrenia research and treatment (7 papers), Amino Acid Enzymes and Metabolism (2 papers) and Tryptophan and brain disorders (2 papers). Edward Amico is often cited by papers focused on Schizophrenia research and treatment (7 papers), Amino Acid Enzymes and Metabolism (2 papers) and Tryptophan and brain disorders (2 papers). Edward Amico collaborates with scholars based in United States and Canada. Edward Amico's co-authors include Donald Goff, Andrew W. Brotman, Joseph T. Coyle, James J. Levitt, Robert W. McCarley, David Schoenfeld, Dara S. Manoach, Doug Hayden, Guochuan Tsai and David C. Henderson and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The Journal of Nervous and Mental Disease.

In The Last Decade

Edward Amico

9 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward Amico United States	8	361	301	194	184	155	9	775
Dragana Bugarski‐Kirola United States	12	242 0.7×	550 1.8×	177 0.9×	166 0.9×	91 0.6×	30	878
Alessandra Solida Switzerland	11	180 0.5×	277 0.9×	281 1.4×	128 0.7×	107 0.7×	32	854
George Garibaldi Switzerland	12	249 0.7×	559 1.9×	195 1.0×	221 1.2×	85 0.5×	21	1000
M. Blanaru Israel	8	167 0.5×	128 0.4×	123 0.6×	112 0.6×	64 0.4×	12	494
Marie‐Louise Matthey Switzerland	5	116 0.3×	237 0.8×	165 0.9×	91 0.5×	56 0.4×	6	674
Eriene Youssef United States	5	128 0.4×	236 0.8×	76 0.4×	116 0.6×	43 0.3×	5	469
Sarah Osborne United Kingdom	14	118 0.3×	279 0.9×	66 0.3×	181 1.0×	29 0.2×	27	744
Carina Ferrari Switzerland	10	102 0.3×	158 0.5×	231 1.2×	75 0.4×	50 0.3×	14	511
Martina von Wilmsdorff Germany	15	78 0.2×	361 1.2×	76 0.4×	100 0.5×	33 0.2×	24	679
Steven Zalcman United States	11	196 0.5×	639 2.1×	116 0.6×	141 0.8×	16 0.1×	13	1.0k

Countries citing papers authored by Edward Amico

Since Specialization

Citations

This map shows the geographic impact of Edward Amico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Amico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Amico more than expected).

Fields of papers citing papers by Edward Amico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Amico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Amico. The network helps show where Edward Amico may publish in the future.

Co-authorship network of co-authors of Edward Amico

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Amico. A scholar is included among the top collaborators of Edward Amico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Amico. Edward Amico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Yurgelun‐Todd, Deborah, Joseph T. Coyle, Staci A. Gruber, et al.. (2005). Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of d-cycloserine. Psychiatry Research Neuroimaging. 138(1). 23–31. 38 indexed citations

2.

Henderson, David C., et al.. (1999). A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia. Biological Psychiatry. 45(4). 512–514. 138 indexed citations

3.

Goff, Donald, Guochuan Tsai, James J. Levitt, et al.. (1999). A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia. Archives of General Psychiatry. 56(1). 21–21. 342 indexed citations

4.

Goff, Donald, et al.. (1998). Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Research. 77(3). 159–166. 27 indexed citations

5.

Goff, Donald, et al.. (1993). A placebo-controlled trial of selegiline (l-deprenyl) in the treatment of tardive dyskinesia. Biological Psychiatry. 33(10). 700–706. 28 indexed citations

6.

Goff, Donald, et al.. (1991). Self-reports of childhood abuse in chronically psychotic patients. Psychiatry Research. 37(1). 73–80. 87 indexed citations

7.

Goff, Donald, et al.. (1991). The Delusion of Possession in Chronically Psychotic Patients. The Journal of Nervous and Mental Disease. 179(9). 567–571. 36 indexed citations

8.

Goff, Donald, et al.. (1991). Dr. Goff and Associates Reply. American Journal of Psychiatry. 148(2). 275–275. 2 indexed citations

9.

Goff, Donald, et al.. (1991). An Open Trial of Buspirone Added to Neuroleptics in Schizophrenic Patients. Journal of Clinical Psychopharmacology. 11(3). 193???197–193???197. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact